Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company’s headquarters. At the event, Masimo’s management team provided an update on the Company’s long-term strategy, including the ...

Masimo alleged Apple used its IP to fix problems with the sensors in Apple Watches. It claimed Apple recruited key experts from Masimo and a spin-off company. Apple asked the court to limit any award ...

Apple Inc. must pay Masimo Corp. $634 million, Masimo announced, after a California federal jury found Apple Watch’s heart-rate alerts infringed a patent for heart- and oxygen-monitoring technology in ...

A federal jury finds Apple infringed Masimo’s pulse oximetry patent, while the ITC has opened a new proceeding to review Apple's redesigned smartwatch.

Amid its multifront legal battle with Apple over its smartwatch’s blood oxygen sensors, Masimo has claimed new ground—including a significant patent infringement verdict in federal court, plus the ...

What just happened? Apple has been dealt a blow in its long-running patent battle against Masimo after a court ordered Cupertino to pay the health tech firm $634 million. The decision came on the same ...

A federal jury in California has found that Apple infringed on a Masimo patent for its pulse oximetry technology and awarded Masimo $634 million in damages, Masimo said Friday. “This is a significant ...

In the latest chapter of the long-running legal war between Apple and medical tech company Masimo, a federal jury in California has ordered Apple to pay $634 million in damages. The jury found that ...

Just a heads up, if you buy something through our links, we may get a small share of the sale. It’s one of the ways we keep the lights on here. Click here for more. A federal jury in California ruled ...

A federal jury in California has determined that Apple must pay medical device company Masimo $634 million in damages for infringing a patent related to blood oxygen monitoring technology. Reuters ...